Program brief
| Form of support | Cash, paid into the bank account |
|---|---|
| Level | Central |
| Run by | Ministry Of Ayush |
| Field | Science, IT & Communications |
| How to apply | Offline / Online |
Contents of this entry
Overview
The scheme-component aims to establish a robust safety monitoring and surveillance system for Ayurveda, Siddha, Unani and Homoeopathy (ASU&H) drugs and to monitor misleading advertisements related to Ayush medicines.
The scheme-component "Pharmacovigilance of ASU&H Drugs Including Surveillance of Misleading Advertisements" under the "Ayush Oushadhi Gunvatta evam Uttpadan Samvardhan Yojana" implemented by the Ministry of Ayush, Government of India, aims to to collect, collate and analyze data to establish evidence for clinical safety of the ASU&H drugs in a scientific manner for documenting clinical evidences of safety of these drugs and undertake surveillance of advertisements of these drugs or on these system of medicines.
Pharmacovigilance initiative for ASU&H drugs aims at-
- inculcating the reporting culture among the consumers as well as ASU&H practitioners to facilitate documentation of Adverse Drug Reactions (ADRs) and instances of misleading advertisements of Ayurveda, Siddha, Unani & Homoeopathy drugs;
- developing a system-wise database of Adverse Drug Reactions of ASU & H drugs; and
- evolving evidence based recommendations regarding the clinical safety and improper advertisements of ASU&H drugs for regulatory actions.
Further facts from the listing
| Scheme type | Central Sector Scheme |
|---|---|
| Scheme for | Infra |
| DBT (direct bank transfer) | No |
Benefits
- Safety Monitoring and Public Health Protection: Establishes a national system for monitoring adverse drug reactions of ASU&H drugs.
- Surveillance of Misleading Advertisements: Strengthens regulatory oversight to detect and act against misleading claims in Ayush drug advertisements.
- Capacity Building and Awareness: Supports training programs, workshops, and awareness campaigns for practitioners and consumers.
- Financial Support for Pharmacovigilance Centres: Provides recurring and non-recurring financial assistance to NPvCC, IPvCs, and PPvCs for manpower, IEC materials, and contingency expenses.
- Evidence-Based Regulatory Action: Generates scientific evidence on drug safety to support regulatory decisions and policy formulation.
Eligibility
- Age
- 18 to 60 years
Eligible Organizations For Peripheral Pharmacovigilance Centres (PPvCs):
- Ayush teaching hospitals recognized under NCISM/NCH Act, IMCC Act, HCC Act, or similar regulatory bodies.
- NABH accredited or Government ASU&H healthcare facilities and research council healthcare institutions.
- Institutions with technical competence and infrastructure for safety monitoring and reporting.
- Institutions with credible outcomes in similar projects are preferred.
- Institutions that previously received Central Government funding must have settled utilization certificates and no adverse remarks.
Eligible Organizations For Intermediary and National Centres:
- Institutions designated by the Ministry of Ayush as National or Intermediary Pharmacovigilance Centres.
Who cannot apply
<br>
Documents
0 of 7 ready
Tick a document once you have it. The ticks stay in this browser only.
Application steps
Offline
- Submission of Concept Note: The applicant institution submits a concept note and proposal to the concerned Intermediary Pharmacovigilance Centre (IPvC).
- Forwarding of Proposal: The proposal must be forwarded with a recommendation from the head of the applicant institution.
- Review by Intermediary Centre: The Intermediary Pharmacovigilance Centre reviews the proposal and forwards it with comments to the National Pharmacovigilance Co-ordination Centre (NPvCC).
- Evaluation by NPvCC: The NPvCC examines the proposal for suitability and eligibility.
- Approval by Project Sanctioning Committee: Upon approval by the Ministry of Ayush Project Sanctioning Committee, the institution is declared a Peripheral Pharmacovigilance Centre.
- Release of Funds: Financial assistance is released periodically based on progress reports and audited statements of expenditure.
Online
Registration Process:
Step 1: Visit the Ayush NGO Portal.
Step 2: Fill in all the mandatory details and upload the relevant documents.
Step 3: Verify the captcha and click on "Register". If required, click "Cancel" to discard changes.
Login Process:
Step 1: Visit the Ayush NGO Portal.
Step 2: Enter the registered email id, password.
Step 3: Type the captcha and click on "Login".
- User Manual: Click here.
- Contact Us: Click here.
Terms used on this page
- Pharmacovigilance
Pharmacovigilance refers to a continuous post-marketing monitoring system to systematically document the safety profile of a medicine. As defined by the World Health Organization, Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse events or any other possible drug related problems.
Questions and answers
What is the objective of the "Pharmacovigilance of ASU&H Drugs Including Surveillance of Misleading Advertisements" scheme-component?
The component aims to establish a national safety monitoring system and surveillance mechanism for misleading advertisements related to ASU&H drugs.
What is pharmacovigilance in ASU&H drugs?
Pharmacovigilance is the systematic monitoring of adverse drug reactions and other safety-related issues associated with Ayurveda, Siddha, Unani and Homoeopathy drugs.
Who implements the pharmacovigilance programme?
The programme is implemented by the Ministry of Ayush through the National Pharmacovigilance Co-ordination Centre and its associated centres.
What is the structure of the pharmacovigilance system?
The system follows a three-tier structure comprising the National Pharmacovigilance Co-ordination Centre, Intermediary Pharmacovigilance Centres, and Peripheral Pharmacovigilance Centres.
Which institutions can become Peripheral Pharmacovigilance Centres?
Ayush teaching hospitals, accredited healthcare facilities, and Government or Research Council healthcare institutions with adequate infrastructure and expertise can become PPvCs.
What activities are supported under this component?
The component supports ADR reporting, surveillance of misleading advertisements, awareness programs, research activities, and data analysis.
How is misleading advertisement surveillance conducted?
Reports on misleading advertisements are collected from practitioners, consumers, industry stakeholders, and healthcare institutions and reviewed for regulatory action.
What type of financial assistance is provided?
Financial assistance is provided for manpower, awareness programs, IEC materials, contingency expenses, and programme management at different pharmacovigilance centres.
How are proposals evaluated?
Proposals are reviewed by the Intermediary Centre and evaluated by the National Pharmacovigilance Co-ordination Centre before approval by the Ministry of Ayush.
Is prior Government funding a disqualification?
No, institutions that received previous Government funding are eligible, provided utilization certificates are settled and there are no adverse remarks.
What are the responsibilities of a Peripheral Pharmacovigilance Centre?
PPvCs are responsible for reporting adverse drug reactions, monitoring misleading advertisements, and coordinating with Intermediary Centres.
How are funds released to selected centres?
Funds are released periodically based on progress reports and audited statements of expenditure submitted to the NPvCC.
Why is this scheme important for public health?
The scheme ensures the safety and reliability of ASU&H drugs and protects consumers from unsafe medicines and misleading claims.
Official portal and guidelines
Applications are submitted only on the provider's own portal. jsrr.in does not accept forms, documents or fees.
Documents from the provider
- Guidelines ayush.gov.in, PDF
jsrr.in is an independent index, not a funding agency or a government body. The provider's official call is final: confirm every condition, amount and date there, and do not pay anyone who offers to apply for you.
This entry reproduces the official listing and has not yet been rewritten or reviewed by our team. Read the official call before you apply.
Ask about this entry